<DOC>
	<DOCNO>NCT00530894</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness device delivery system ( transfemoral transapical ) high risk , symptomatic patient severe aortic stenosis .</brief_summary>
	<brief_title>THE PARTNER TRIAL : Placement AoRTic TraNscathetER Valve Trial</brief_title>
	<detailed_description>Subjects undergo physical exam screening test perform determine either A ) patient high surgical risk B ) candidate surgery . They randomize ( like flip coin ) investigational device implant receive current surgical medical management available .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Inclusion Criteria Cohort A 1 . Patients must comorbidities surgeon cardiologist CoPIs concur predict risk operative mortality ≥15 % and/or minimum STS score 10 2 . Patient senile degenerative aortic valve stenosis echocardiographically derive criterion : mean gradient &gt; 40 mmHg jet velocity great 4.0 m/s initial aortic valve area &lt; 0.8 cm2 3 . Patient symptomatic his/her aortic valve stenosis , demonstrate NYHA Functional Class II great 4 . The subject subject 's legal representative inform nature study , agree provision provide write informed consent approve IRB respective clinical site 5 . The subject treating physician agree subject return require postprocedure followup visit Cohort B All candidate Cohort B study must meet # 2 , 3 , 4 , 5 criterion 6 . The subject , formal consults cardiologist two cardiovascular surgeon agree medical factor preclude operation , base conclusion probability death serious , irreversible morbidity exceed probability meaningful improvement . Specifically , probability death serious , irreversible morbidity exceed 50 % . Exclusion Criteria 1 . Evidence acute myocardial infarction ≤ 1month intend treatment 2 . Aortic valve congenital unicuspid bicuspid valve ; noncalcified 3 . Mixed aortic valve disease ( aortic stenosis aortic regurgitation predominant aortic regurgitation &gt; 3+ ) 4 . Any therapeutic invasive cardiac procedure perform within 30 day index procedure , ( 6 month procedure drug elute coronary stent implantation ) 5 . Preexisting prosthetic heart valve position , prosthetic ring , severe ( great 3+ ) mitral insufficiency 6 . Blood dyscrasia define : Leukopenia , acute anemia , thrombocytopenia , history bleed diathesis coagulopathy 7 . Untreated clinically significant coronary artery disease require revascularization 8 . Hemodynamic instability require inotropic support mechanical heart assistance . 9 . Need emergency surgery reason 10 . Hypertrophic cardiomyopathy without obstruction 11 . Severe ventricular dysfunction LVEF &lt; 20 12 . Echocardiographic evidence intracardiac mass , thrombus vegetation 13 . Active peptic ulcer upper GI bleeding within prior 3 month 14 . A known hypersensitivity contraindication aspirin , heparin , ticlopidine , clopidogrel , sensitivity contrast medium , adequately premedicated 15 . Native aortic annulus size &lt; 16mm &gt; 24mm per baseline echo estimate LVOT 16 . Patient offer surgery refuse surgery . 17 . Recent ( within 6 month ) CVA TIA 18 . Renal insufficiency and/or end stage renal disease require chronic dialysis 19 . Life expectancy &lt; 12 month due noncardiac comorbid condition . 20 . Significant aortic disease , include abdominal aortic thoracic aneurysm define maximal luminal diameter 5cm great ; mark tortuosity ( hyperacute bend ) , aortic arch atheroma narrowing ( especially calcification surface irregularity ) abdominal thoracic aorta , severe `` unfolding '' tortuosity thoracic aorta ( applicable transfemoral patient ) . 21 . Iliofemoral vessel characteristic would preclude safe placement 22F 24F introducer sheath severe obstructive calcification , severe tortuosity vessel size le 7 mm diameter ( applicable transfemoral patient ) . 22 . Currently participate investigational drug another device study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Valvular Heart Disease</keyword>
	<keyword>Critical/Severe Aortic Stenosis</keyword>
	<keyword>High risk symptomatic patient</keyword>
</DOC>